课题基金 / 基金详情

Ocular Hypertension Treatment Study: Coordinating Center

Ocular Hypertension Treatment Study: Coordinating Center
高眼压治疗研究:协调中心
批准号:
7917820
负责人:
MAE O GORDON
金额:
$130.18万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2012-09-29

项目摘要

项目成果

MAE O GORDON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The primary specific aim of the OHTS II cohort study is to determine if there is a penalty for delaying treatment in ocular hypertension. The primary specific aim will be tested by comparing the long-term cumulative incidence of POAG and adverse events in the original observation participants in OHTS I who start treatment in OHTS II to the long-term cumulative incidence in medication participants who received medication throughout OHTS I and who continue treatment in OHTS II (Primary Specific Aim). The specific aim of the Coordinating Center is to provide overall scientific leadership and operational support to accomplish the primary and secondary specific aims of OHTS II by: 1. Developing, distributing and maintaining a detailed Manual of Procedures 2. Training and certifying clinical staff in OHTS II study protocol and procedures 3. Monitoring adherence to the OHTS II protocol and providing feedback to clinic staff and resource centers 4. Ensuring collaboration between clinics and resource centers 5. Monitoring efficacy and safety at semi-annual intervals and as requested by the Data and Safety Monitoring Committee 6. Receiving, editing, storing and analyzing data from participating clinics, Visual Field Reading Center, Optic Disc Reading Center, Confocal Scanning Laser Ophthalmoscope Reading Center and the Short Wave Length Perimetry Reading Center. 7. Providing methodological and statistical expertise in the preparation of presentations and publications 8. Developing plans for the orderly close-out of the study including participants, clinics, and resource centers 9. Archiving and documenting study data.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
A Joint Model for Prognostic Effect of Biomarker Variability on Outcomes: long-term intraocular pressure (IOP) fluctuation on the risk of developing primary open-angle glaucoma (POAG).
生物标志物变异对结果的预后影响的联合模型:长期眼压(IOP)波动对发生原发性开角型青光眼(POAG)风险的影响。
DOI: --
发表时间: 2011
期刊: JP journal of biostatistics
影响因子: 0.1
作者: [Gao,Feng, Miller,JPhilip, Miglior,Stefano, Beiser,JuliaA, Torri,Valter, Kass,MichaelA, Gordon,MaeO]
通讯作者: Gordon,MaeO
DOI: 10.1186/1471-2288-12-151
发表时间: 2012-10-04
期刊: BMC medical research methodology
影响因子: 4
作者: [Gao F, Miller JP, Miglior S, Beiser JA, Torri V, Kass MA, Gordon MO]
通讯作者: Gordon MO
DOI: 10.1016/j.ogla.2023.06.005
发表时间: 2023
期刊: Ophthalmology. Glaucoma
影响因子: --
作者: [Leshno,Ari, DeMoraes,CarlosGustavo, Cioffi,GeorgeA, Kass,Michael, Gordon,Mae, Liebmann,JeffreyM]
通讯作者: Liebmann,JeffreyM
Long-Term Quality of Life in the Ocular Hypertension Treatment Study Cohort
  • 批准号:
    10667711
  • 项目类别:
  • 资助金额:
    $24.63万
  • 财政年份:
    2023
  • 负责人:
    MAE O GORDON
  • 依托单位:
Resubmission: Latent Class Trajectory Analysis in the OHTS Study
  • 批准号:
    10675764
  • 项目类别:
  • 资助金额:
    $23.33万
  • 财政年份:
    2022
  • 负责人:
    MAE O GORDON
  • 依托单位:
Resubmission: Latent Class Trajectory Analysis in the OHTS Study
  • 批准号:
    10540153
  • 项目类别:
  • 资助金额:
    $19.65万
  • 财政年份:
    2022
  • 负责人:
    MAE O GORDON
  • 依托单位:
Innovative Analytical Methods for Repeated Measures in the OHTS Study
  • 批准号:
    10219276
  • 项目类别:
  • 资助金额:
    $23.59万
  • 财政年份:
    2020
  • 负责人:
    MAE O GORDON
  • 依托单位:
海外基金